1. Chen, W, Zheng, R, Zhang, S, et al. Cancer incidence and mortality in China, 2013. Cancer Lett 2017; 401: 63–71.
Google Scholar | Crossref | Medline2. Huang, J, Chen, YX, Zhang, B. IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2. Gastric Cancer 2020; 23(1): 23–38.
Google Scholar | Crossref | Medline3. Puneet, Kazmi, HR, Kumari, S, et al. epigenetic mechanisms and events in gastric cancer-emerging novel biomarkers. Pathol Oncol Res 2018; 24: 757–770.
Google Scholar | Crossref | Medline4. Pommier, Y, Huang, SY, Gao, R, et al. Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2). DNA Repair (Amst) 2014; 19: 114–129.
Google Scholar | Crossref | Medline5. Jakobsen, AK, Lauridsen, KL, Samuel, EB, et al. Correlation between topoisomerase I and tyrosyl-DNA phosphodiesterase 1 activities in non-small cell lung cancer tissue. Exp Mol Pathol 2015; 99: 56–64.
Google Scholar | Crossref | Medline6. Meisenberg, C, Gilbert, DC, Chalmers, A, et al. Clinical and cellular roles for TDP1 and TOP1 in modulating colorectal cancer response to irinotecan. Mol Cancer Ther 2015; 14: 575–585.
Google Scholar | Crossref | Medline7. Meisenberg, C, Ward, SE, Schmid, P, et al. TDP1/TOP1 ratio as a promising indicator for the response of small cell lung cancer to Topotecan. J Cancer Sci Ther 2014; 6: 258–267.
Google Scholar | Crossref | Medline8. Elsayed, MSA, Su, Y, Wang, P, et al. Design and synthesis of chlorinated and fluorinated 7-Azaindenoisoquinolines as potent cytotoxic anticancer agents that inhibit topoisomerase I. J Med Chem 2017; 60: 5364–5376.
Google Scholar | Crossref | Medline9. Zhang, J, Jin, M, Chen, X, et al. Loss of PPM1F expression predicts tumour recurrence and is negatively regulated by miR-590-3p in gastric cancer. Cell Prolif 2018; 51: e12444.
Google Scholar | Crossref | Medline10. Wang, T, Hao, D, Yang, S, et al. miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer. Cell Death Dis 2019; 10: 495.
Google Scholar | Crossref | Medline11. Oztemur Islakoglu, Y, Noyan, S, Aydos, A, et al. Meta-microRNA biomarker signatures to classify breast cancer subtypes. OMICS 2018; 22: 709–716.
Google Scholar | Crossref | Medline12. Fu, X, Mao, X, Wang, Y, et al. Let-7c-5p inhibits cell proliferation and induces cell apoptosis by targeting ERCC6 in breast cancer. Oncol Rep 2017; 38: 1851–1856.
Google Scholar | Crossref | Medline13. Mortazavi, D, Sharifi, M. Antiproliferative effect of upregulation of hsa-let-7c-5p in human acute erythroleukemia cells. Cytotechnology 2018; 70: 1509–1518.
Google Scholar | Crossref | Medline